Author of the publication

Parameter estimation of qualitative biological regulatory networks on high performance computing hardware.

, , , , , , , and . BMC Syst. Biol., 12 (1): 146:1-146:15 (2018)

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

 

Other publications of authors with the same name

On the trail of EHEC/EAEC--unraveling the gene regulatory networks of human pathogenic Escherichia coli bacteria., , , , , , , , , and . Integrative biology : quantitative biosciences from nano to macro, 4 (7): 728--733 (Jul 9, 2012)Success Factors of Artificial Intelligence Implementation in Healthcare., , , and . Frontiers Digit. Health, (2021)CoryneRegNet 6.0—Updated database content, new analysis methods and novel features focusing on community demands, , , , and . Nucleic Acids Research, 40 (D1): D610--D614 (Jan 1, 2012)Computational Lipidomics and Lipid Bioinformatics: Filling In the Blanks., and . J. Integr. Bioinform., (2016)KeyPathwayMiner 4.0: condition-specific pathway analysis by combining multiple omics studies and networks with Cytoscape., , , , , , , , and . BMC Syst. Biol., (2014)Computational Lipidomics.. Encyclopedia of Bioinformatics and Computational Biology (2), Elsevier, (2019)Federated machine learning for a facilitated implementation of Artificial Intelligence in healthcare - a proof of concept study for the prediction of coronary artery calcification scores., , , , , , , , and . J. Integr. Bioinform., (2022)Parameter estimation of qualitative biological regulatory networks on high performance computing hardware., , , , , , , and . BMC Syst. Biol., 12 (1): 146:1-146:15 (2018)Lipid network and moiety analysis for revealing enzymatic dysregulation and mechanistic alterations from lipidomics data., , , , , and . Briefings Bioinform., (January 2023)Lessons from the COVID-19 pandemic for advancing computational drug repurposing strategies., , , , , , , and . Nat. Comput. Sci., 1 (1): 33-41 (2021)